India reports over 600 COVID-19 cases after 117 days
India reports over 600 COVID-19 cases after 117 days The country had recorded 656 cases on November 18 last year. The COVID case tally was recorded at 4.46 crore (4,46,91,956). The national COVID-19 recovery rate has been recorded at 98.80 per cent and the number of people who have recuperated from the disease surged to 4,41,56,970. https://ift.tt/xeFhbgo
U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids
U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids The amended authorization is for children six months through four years of age who have completed their initial three-dose vaccination with Pfizer's original shot. https://ift.tt/xeFhbgo
India 8th most polluted country in world, Delhi 4th most polluted city
India 8th most polluted country in world, Delhi 4th most polluted city India was the world's eighth most polluted country in 2022 with an annual average PM2.5 concentration of 53.3 micrograms per cubic metre, according to the fifth annual World Air Quality Report 2022 by IQAir released Tuesday. In 2021, India was ranked the fifth most polluted country with an average PM2.5 level of 58.1 micrograms per cubic metre. https://ift.tt/xeFhbgo
Toxic ‘forever chemicals’ found in toilet paper around the world
Toxic ‘forever chemicals’ found in toilet paper around the world
https://ift.tt/MJUK6Cs March 13, 2023 at 04:50PM https://ift.tt/1L0dhnX
 |
submitted by /u/app1etree [link] [comments] |
India's chemical demand likely to jump to USD 1,000 billion by 2040
India's chemical demand likely to jump to USD 1,000 billion by 2040 Coupled with promoters' focus on high profitability and a culture of process innovation, Indian chemical companies generate one of the highest EBITDA per unit of investment in fixed assets. "This is evident from global leadership of multiple Indian firms across segments like agrochemicals, pharma intermediates, dyes and pigments, carbon black etc," said McKinsey's report with title, "India: The next chemicals manufacturing hub." https://ift.tt/CzglnIm
USFDA inspection at Karakhadi unit completed without any observations: Alembic
USFDA inspection at Karakhadi unit completed without any observations: Alembic According to a statement from the Vadodara-headquartered pharma firm, the ANDA was filed by Aleor Dermaceuticals (Aleor) which was amalgamated with Alembic. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US. Desonide Cream, 0.05 per cent, is a low-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. https://ift.tt/CzglnIm
Subscribe to:
Posts (Atom)
Popular Posts
|
